
We like to challenge the conventional. We’re curious. We’re not satisfied with ‘normal’. We always think there’s a better way.
This is why we launched new Flexadin Advanced at BSAVA yesterday. It brings together two powerful ingredients – Undenatured Type-II Collagen (UC-II®) and purified extracts of the Boswellia Serrata plant.
We had the pleasure of hosting nearly 40 vets at our launch event, where attendees had a chance to experience the industry’s first virtual reality headset with a fantastic 3D animation designed to educate vets, nurses and pet owners about the mechanisms of osteoarthritis and UC-II. Speaker Dr Kevin Owen, Head of Scientific Affairs at Lonza presented interesting research studies and evidence on how UC-II, a unique molecule, can improve and prolong a dog’s mobility. Thank you for those of you who have joined and for making this such a successful and enjoyable evening.
If you have any questions about the New Flexadin Advanced with UC-II© and Boswellia Serrata, please contact us on UK_customerservices@vetoquinol.com and one of our team will be happy to answer your enquiry.

Latest news
VETOQUINOL’S NEW THREE-MONTHLY FELINE PARASITICIDE RECEIVES MARKETING AUTHORISATION FROM THE VMD
Vetoquinol UK has been granted marketing authorisation by the VMD for Felpreva – a new endectocide...
January 2022
Battling Burn Out Webinar Series
THE UK VETERINARY INDUSTRY IS CURRENTLY EXPERIENCING A MENTAL HEALTH CRISIS. We know that many of...
October 2021
Vetoquinol UK achieves bronze accreditation with Investors in the Environment
Veterinary pharmaceuticals company, Vetoquinol UK, has achieved bronze accreditation with Investors...
October 2021